Salman Rahman

Current Organisation: VASGEN LIMITED
(some projects in the list below may not be associated with this organisation)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£173,434

Nov 14 - Jan 16

Evaluating Novel Monoclonal Antibodies to Target ADAM15 for a Potential Novel Ocular Anti-Angiogenesis Therapy

Innovate UK award to VASGEN LIMITED and Salman Rahman

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}